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A B S T R A C T
Objectives: Both atrial ﬁbrillation (AF) and vascular disease share several risk factors and the two diseases
often coexist. The patients with AF were reported to have a decreased ankle-brachial index (ABI).
However, ABI was also reported to have an inverse relationship with heart rate (HR). Because AF patients
often have a transiently or persistently rapid HR, this study aimed to assess whether AF was signiﬁcantly
associated with decreased ABI and whether HR could signiﬁcantly inﬂuence the relationship between
AF and ABI.
Methods: We included 166 AF and 1336 non-AF patients from subjects undergoing echocardiographic
examinations. ABI was measured using an ABI-form device.
Results: Compared to non-AF patients, AF patients had a decreased ABI (p < 0.001). In a multivariate
model, including covariates of age, sex, blood pressures, etc., the presence of AF was signiﬁcantly
associated with low ABI (b = 0.069, p = 0.026). However, further adjustment for HR made this
association disappear (p = 0.971).
Conclusion: This study demonstrated that the presence of AF was associated with decreased ABI, but this
association became insigniﬁcant after further adjustment for HR, which suggested HR could signiﬁcantly
inﬂuence the relationship between AF and ABI.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atrial ﬁbrillation (AF) has been shown to be a major risk factor
of vascular disease [1–3] and vascular disease similarly has been
found to increase the risk of AF [1,4]. Both AF and vascular disease
share several risk factors, including old age, obesity, heart failure,
diabetes, and hypertension and the two diseases often coexist
[4–6]. Therefore, the presence of AF may have an inﬂuence on
vascular function as shown by ankle-brachial index (ABI).
ABI is an easy-to-use, non-invasive, and reliable diagnostic tool
for peripheral arterial occlusive disease (PAOD) [7,8]. An ABI <0.9
has not only been established as a reliable diagnostic marker for* Corresponding author at: Department of Internal Medicine, Kaohsiung
Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, 482, Shan-Ming
Rd., Hsiao-Kang Dist., 812 Kaohsiung, Taiwan, ROC. Tel.: +886 7 8036783 3441;
fax: +886 7 8063346.
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0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsPAOD, but also a strong predictor for overall and cardiovascular
mortality [9–11]. A clinical device, ABI-form (VP1000; Colin Co.
Ltd., Komaki, Japan), has been developed to automatically and
simultaneously record pulse waves of the brachial and posterior
tibial arteries, using an automated oscillometric method. Using
this device, we can easily and automatically calculate the ABI and
brachial-ankle pulse wave velocity (baPWV) [12,13].
AF patients often have a transiently or persistently rapid heart
rate (HR). Recently, we reported that HR signiﬁcantly inﬂuences
the relationship between AF and arterial stiffness [14]. Further-
more, several studies have demonstrated that HR has an inverse
correlation with ABI [15–17]. Although tachycardia-induced
cardiomyopathy is a well-known reason of cardiac dysfunction
in patients with AF [18], whether HR may signiﬁcantly inﬂuence
the relationship between AF and ABI has not been studied. Hence,
the ﬁrst aim of this study was to compare ABI between patients
with and without AF and to determine whether AF patients had a
decreased ABI. The second aim of this study was to assess whether
AF per se was a major determinant of decreased ABI and whether reserved.
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and ABI.
Methods
Study subjects
This was a cross-sectional study. Study subjects were pros-
pectively included from a group of patients who arranged for
echocardiographic examinations at Kaohsiung Municipal Hsiao-
Kang Hospital. Patients with inadequate image visualization
were excluded. AF patients were consecutively included.
However, non-AF patients were not consecutively included
because ABI measurement must be performed within 10 min
after the completion of echocardiographic examination. Finally,
166 patients with persistent or permanent AF and 1336 non-AF
patients were included in this study. The study protocol was
approved by the institutional review board of the Kaohsiung
Medical University Hospital (KMUH-IRB). Informed consent was
obtained in written form from patients and all clinical investiga-
tions were conducted according to the principles expressed in the
Declaration of Helsinki. The patients gave consent for the
publication of the clinical details.
Assessment of ABI, baPWV, and HR
The values of ABI, baPWV, and HR were measured by using an
ABI-form device (VP1000), which automatically and simultaneous-
ly measured blood pressures in both arms and ankles using an
oscillometric method [12,13]. The ABI was calculated by the ratio
of the ankle systolic blood pressure (SBP) divided by the higher SBP
of the arms. For measuring baPWV, pulse waves obtained from the
brachial and tibial arteries were recorded simultaneously and
the transmission time, which was deﬁned as the time interval
between the initial increase in brachial and tibial waveforms, was
determined. The transmission distance from the arm to each ankle
was calculated according to body height. The baPWV value was
automatically computed as the transmission distance divided by
the transmission time. In addition, for measuring HR, nine seconds
of electrocardiographic signal were recorded and four consecutive
beats if HR <120 beats/min or eight consecutive beats if HR
3120 beats/min during this period was automatically analyzed
and then averaged to get the mean HR for later analysis. In non-AF
patients, the examination of ABI-form device was performed once.
However, in AF patients, the examination of ABI-form device was
performed thrice. The left and right ABI values were obtained by
averaging three left and right ABI values acquired from the
repeated examinations in AF patients. After obtaining bilateral ABI
values, the lower one was used for later analysis. In addition, in AF
patients, the six values of baPWV, the three values of HR, and the
six values of SBP and diastolic blood pressure (DBP) from both arms
obtained from the repeated examinations were averaged for later
analysis.
Evaluation of left ventricular systolic function
The echocardiographic examination was performed by one
experienced cardiologist with a VIVID 7 (General Electric Medical
Systems, Horten, Norway), with the participant respiring quietly
in the left decubitus position. The cardiologist was blind to the
other data. Left ventricular ejection fraction (LVEF) was measured
using the modiﬁed Simpson’s method. In non-AF patients,
LVEF was measured and averaged from 3 consecutive beats. In
AF patients, LVEF was determined using the index-beat method
[19–21].Collection of demographic, medical and laboratory data
Demographic and medical data including age, gender, and
history of diabetes mellitus, hypertension, cerebrovascular acci-
dent (CVA), and chronic heart failure (CHF) were obtained from
medical records or interviews with patients. CHF was deﬁned
according to Framingham criteria. Body mass index (BMI) was
calculated as the ratio of weight in kilograms divided by the
square of height in meters. Laboratory data including total
cholesterol and triglyceride values were also collected. The value
of estimated glomerular ﬁltration rate (eGFR) was calculated
using the 4-variable equation in the Modiﬁcation of Diet in Renal
Disease study [22]. In addition, information regarding patient
medications including angiotensin-converting enzyme inhibitors
(ACEIs), angiotensin II receptor blockers (ARBs), b-blockers,
calcium channel blockers (CCBs), and diuretics during the study
period was obtained from medical records.
Statistical analysis
SPSS 18.0 software (SPSS, Chicago, IL, USA) was used for
statistical analysis. Data were expressed as mean  standard
deviation or percentage. Continuous and categorical variables
between groups were compared by independent samples t-test
and Chi-square test, respectively. The multiple linear regression
analysis was employed to identify the determinants of ABI. The
impact of HR on the relationship between AF and ABI was assessed by
a modiﬁed procedure in 3 modeling steps. The ﬁrst model consisted of
age and sex. The second model consisted of the signiﬁcant variables
in the univariate analysis except HR. The ﬁnal step was adding HR.
All tests were 2-sided and the level of signiﬁcance was established
as p < 0.05.
Results
Table 1 shows the comparison of baseline characteristics
between patients with and without AF. Compared to patients
without AF, patients with AF had a lower ABI, higher prevalence of
ABI <1.0, older age, lower prevalence of female gender, higher HR,
lower SBP and DBP, higher prevalence of CVA and CHF, lower total
cholesterol and triglyceride, and higher percentage of ACEI and/or
ARB and diuretic use.
In a univariate analysis, ABI had a negative correlation with the
presence of AF, age, female gender, HR, SBP, diabetes, CVA, CHF,
total cholesterol, LVEF <50%, baPWV, and use of ACEIs and/or ARBs
and diuretics and positive correlation with DBP, BMI, and eGFR.
Table 2 displays the standardized coefﬁcient b estimates for ABI by
the presence of AF with and without adjustment for demographic,
clinical, LVEF <50%, baPWV, biochemical parameters, and HR.
The presence of AF was associated with ABI in the age- and
sex-adjusted model (standardized coefﬁcient b = 0.101; 95%
conﬁdence interval (CI), 0.063 to 0.020; p < 0.001) and in
the multivariate model adjusting for the signiﬁcant variables in
the univariate analysis except HR (standardized coefﬁcient
b = 0.069; 95% CI, 0.052 to 0.003; p = 0.026). This relation
between AF and ABI disappeared after further adjustment for HR
(p = 0.971). Because high value of ABI (ABI 31.3) could be related to
poor arterial distensibility resulting from stiffness and calciﬁcation,
we performed a subgroup analysis in the 1467 patients with ABI
<1.3 (Table 3). The relation between AF and ABI still disappeared
after further adjustment for HR (p = 0.957).
Table 4 shows the univariate and multivariate correlates of ABI
in all study patients. After the multivariate analysis, old age,
increased HR, decreased BMI, history of CVA and CHF, high total
cholesterol, and use of diuretics were the major determinants of
decreased ABI in all study patients. We also performed a subgroup
Table 3
Relation of atrial ﬁbrillation to ABI in subgroup patients with ABI <1.3.
Atrial ﬁbrillation ABI
Standardized coefﬁcient b (95% CI) p
Unadjusted 0.120 (0.069, 0.028) <0.001
Age and sex adjusted 0.100 (0.061, 0.019) <0.001
Multivariate adjusted (1) 0.065 (0.049, 0.001) 0.039
Multivariate adjusted (2) – 0.957
Values expressed as standardized coefﬁcient b [95% conﬁdence interval (CI)].
Multivariate model (1): adjusted for age, sex, SBP, DBP, BMI, diabetes mellitus,
CVA, CHF, eGFR, LVEF <50%, baPWV, total cholesterol, ACEI/ARB use, diuretic
use Multivariate model (2): model (1) + heart rate.
ABI, ankle-brachial index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; BMI, body mass index; CVA, cerebrovascular accident; CHF, chronic
heart failure; eGFR, estimated glomerular ﬁltration rate; LVEF, left ventricular
ejection fraction; baPWV, brachial-ankle pulse wave velocity; ACEI, angioten-
sin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
Table 1
Comparison of baseline characteristics between patients with and without AF.
Characteristics Patients
with AF
(n = 166)
Patients
without AF
(n = 1336)
p
ABI 1.06  0.14 1.11  0.13 <0.001
ABI <0.9 16 (9.6%) 75 (5.6%) 0.055
ABI <1.0 32 (19.4%) 140 (10.5%) 0.002
Age (years) 69  10 61  14 <0.001
Female gender 55 (33%) 588 (44%) 0.008
Heart rate (min1) 85  18 70  13 <0.001
SBP (mmHg) 132  17 136  21 0.031
DBP (mmHg) 75  11 77  12 0.010
BMI (kg/m2) 26.2  4.2 26.1  4.0 0.706
Diabetes mellitus 49 (30%) 381 (29%) 0.681
CVA 28 (17%) 80 (6%) <0.001
CHF 50 (30%) 114 (9%) <0.001
Total cholesterol (mg/dL) 177  37 191  44 <0.001
Triglyceride (mg/dL) 122  72 155  150 0.016
eGFR (mL/min/1.73 m2) 58  18 57  21 0.544
LVEF (%) 47  24 58  19 <0.001
baPWV (cm/s) 1940  526 1731  438 <0.001
Medications
ACEIs and/or ARBs 102 (61%) 721 (54%) 0.039
b Blockers 78 (47%) 541 (40%) 0.075
CCBs 54 (33%) 472 (35%) 0.569
Diuretics 70 (42%) 378 (28%) <0.001
ABI, ankle-brachial index; AF, atrial ﬁbrillation; SBP, systolic blood pressure;
DBP, diastolic blood pressure; BMI, body mass index; CVA, cerebrovascular
accident; CHF, chronic heart failure; eGFR, estimated glomerular ﬁltration rate;
LVEF, left ventricular ejection fraction; baPWV, brachial-ankle pulse wave
velocity; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II
receptor blocker; CCB, calcium channel blocker.
Table 2
Relation of atrial ﬁbrillation to ABI.
Atrial ﬁbrillation ABI
Standardized coefﬁcient, b (95% CI) p
Unadjusted 0.119 (0.070, 0.028) <0.001
Age and sex adjusted 0.101 (0.063, 0.020) <0.001
Multivariate adjusted (1) 0.069 (0.052, 0.003) 0.026
Multivariate adjusted (2) – 0.971
Values expressed as standardized coefﬁcient b [95% conﬁdence interval (CI)].
Multivariate model (1): adjusted for age, sex, SBP, DBP, BMI, diabetes mellitus,
CVA, CHF, eGFR, LVEF <50%, baPWV, total cholesterol, ACEI/ARB use, diuretic
use Multivariate model (2): model (1) + heart rate.
ABI, ankle-brachial index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; BMI, body mass index; CVA, cerebrovascular accident; CHF, chronic
heart failure; eGFR, estimated glomerular ﬁltration rate; LVEF, left ventricular
ejection fraction; baPWV, brachial-ankle pulse wave velocity; ACEI, angioten-
sin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker.
Table 5
Univariate and multivariate correlates of ABI in subgroup of patients with ABI <1.3.
Univariate analysis Multivariate analysis
Standardized
coefﬁcient b
p Standardized
coefﬁcient b
p
Age (years) 0.152 <0.001 – –
Female gender 0.071 0.007 – –
Heart rate (min1) 0.195 <0.001 0.213 <0.001
SBP (mmHg) 0.059 0.026 0.296 <0.001
DBP (mmHg) 0.082 0.002 0.314 <0.001
BMI (kg/m2) 0.089 0.001 0.091 0.001
Atrial ﬁbrillation 0.120 <0.001 – –
Diabetes mellitus 0.124 <0.001 0.057 0.038
CVA 0.057 <0.001 0.113 <0.001
CHF 0.198 <0.001 0.107 <0.001
Total cholesterol (mg/dL) 0.05 0.092
Triglyceride (mg/dL) 0.029 0.325
eGFR (mL/min/1.73 m2) 0.150 <0.001 – –
Medications
ACEIs and/or ARBs 0.068 0.010 – –
b Blockers 0.003 0.916
CCBs 0.013 0.620
Diuretics 0.116 <0.001 0.066 0.019
ABI, ankle-brachial index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; BMI, body mass index; CVA, cerebrovascular accident; CHF, chronic
heart failure; eGFR, estimated glomerular ﬁltration rate; ACEI, angiotensin-
converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium
channel blocker.
Table 4
Univariate and multivariate correlates of ABI in all study patients.
Univariate analysis Multivariate analysis
Standardized
coefﬁcient b
p Standardized
coefﬁcient b
p
Age (years) 0.152 <0.001 0.132 <0.001
Female gender 0.087 0.001 – –
Heart rate (min1) 0.195 <0.001 0.159 <0.001
SBP (mmHg) 0.061 0.019 – –
DBP (mmHg) 0.073 0.005 – –
BMI (kg/m2) 0.097 <0.001 0.095 0.002
Atrial ﬁbrillation 0.119 <0.001 – –
Diabetes mellitus 0.122 <0.001 – –
CVA 0.181 <0.001 0.119 <0.001
CHF 0.112 <0.001 0.105 0.001
Total cholesterol (mg/dL) 0.058 0.047 0.106 <0.001
Triglyceride (mg/dL) 0.033 0.264
eGFR (mL/min/1.73 m2) 0.145 <0.001 – –
Medications
ACEIs and/or ARBs 0.059 0.022 – –
b Blockers 0.004 0.874
CCBs 0.013 0.610
Diuretics 0.109 <0.001 0.085 0.007
ABI, ankle-brachial index; SBP, systolic blood pressure; DBP, diastolic blood
pressure; BMI, body mass index; CVA, cerebrovascular accident; CHF, chronic
heart failure; eGFR, estimated glomerular ﬁltration rate; ACEI, angiotensin-
converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium
channel blocker.
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multivariate analysis, increased HR and SBP, decreased DBP and
BMI, history of diabetes, CVA, and CHF, and use of diuretics were
the major determinants of decreased ABI in subgroup patients
with ABI <1.3.
Discussion
In the present study, we compared ABI between patients with
and without AF and evaluated the determinants of ABI. We found
that compared to non-AF patients, AF patients had a lower ABI.
AF was signiﬁcantly associated with decreased ABI even after
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However, further adjustment for HR made the association between
AF and ABI disappear. Hence, HR had an important impact on the
relationship between AF and ABI. In addition, HR had a negative
correlation with ABI both in all study patients and in subgroup
patients with ABI <1.3 in the multivariate analysis.
AF is the most common cardiac arrhythmia in clinical practice. AF
shares several risk factors and pathophysiological features with
atherosclerosis. In fact, PAOD is highly prevalent in AF patients and is
associated with increased mortality [1,4–6]. Masˇanauskiene˙ E et al.
reported that the patients with permanent AF had a signiﬁcantly
lower ABI and higher prevalence of PAOD than those without AF in a
univariate analysis [23], but they did not conﬁrm the ﬁndings in a
multivariate analysis. In our study, we also demonstrated that
patients with AF had a decreased ABI than those without AF. After
adjustment for multiple confounding factors except HR, this
association remained signiﬁcant. However, after further adjustment
for HR, such association disappeared. Hence, HR might have a
signiﬁcant inﬂuence on the relationship between AF and ABI.
Many studies showing post-exercise ABI decreased not only in
normal subjects but also in patients with PAOD [24–27]. Generally,
HR increased in response to the extent of exercise. The possible
mechanism of decreased ABI in the post-exercise patients might be
related to shunting of blood to active muscles during exercise.
With leg exercise, SBP increased in the central circulation, as
measured in the arms, but SBP of ankle decreased owing to
vasodilation in exercising muscle which led to a mild decrease in
the ABI in normal subjects [27]. This phenomenon became more
signiﬁcant in the patients with PAOD because ankle SBP decreased
more during exercise due to severity of arterial obstruction.
However, Desvaux et al. reported that ABI decreased when HR was
increased in response to both exercise and heat stress in healthy
subjects. They suggested that decreased ABI following exercise was
due to turbulence at high ﬂow levels, rather than the shunting of
blood to active muscles in exercise [24]. In addition, some studies
demonstrated that there was an inverse correlation between ABI
and HR [15–17]. Abraham et al. reported that in screening for
PAOD in the general population with the use of ABI, the HR at
which arterial pressure measurements were performed should
be mentioned [16]. Our previous study also showed that ABI
decreased signiﬁcantly when HR was increased either by atrial or
ventricular pacing in young and middle-aged patients without
signiﬁcant organic heart disease [17]. In the present study, AF per
se was negatively associated with ABI in the univariate analysis
and some multivariate analyses, but this association became
insigniﬁcant after further adjustment for HR. Hence, higher HR in
our AF patients might cause their lower ABI.
CVA, CHF, and obesity were reported to be risk factors for PAOD
formation [28–31]. Our present study similarly found that the
presence of CVA and CHF and high BMI were associated with
decreased ABI both in all study patients and in subgroup patients
with ABI <1.3 in the multivariate analysis. In addition, hyper-
tension was reported to have a strong association with PAOD
[29,32–33]. The Framingham study also showed there was a 2.5–4-
fold increase in the risk of developing intermittent claudication
in patients with hypertension [32]. In this study, the multivariate
analysis also demonstrated that increased SBP was associated with
decreased ABI in patients with ABI <1.3.
Study limitations
First, the majority of our patients were treated chronically
with antihypertensive medications. For ethical reasons, we did
not withdraw these medications. Hence, we could not exclude the
inﬂuence of antihypertensive agents on our present ﬁndings.
However, in order to minimize the inﬂuence of drugs, we hadadded different classes of antihypertensive drugs in the multivari-
ate analysis. Second, although we averaged the values of ABI,
baPWV, HR, SBP, and DBP from 3-time examination in AF patients,
the beat-to-beat variation of these values during AF might make
the measurement technically difﬁcult and inaccurate. Third,
because we did not measure ABI values in different HR levels in
the same patient, we could not evaluate what HR level would
signiﬁcantly affect the ABI value from the present study. In
addition, only resting HR was measured in this study. The
evaluation of HR by 24-hour Holter monitoring should be more
accurate and reliable than only evaluation of resting HR.
Conclusion
This study demonstrated that the presence of AF with higher HR
was associated with decreased ABI in some multivariate models,
but this association became insigniﬁcant after further adjustment
for HR, which suggested HR could signiﬁcantly inﬂuence the
relationship between AF and ABI. Hence, a negative association
between AF and ABI was probably confounded by an increased HR
in AF patients.
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